United Therapeutics (UTHR) Misses Q3 EPS by 16c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $554.34 -1.66%
Revenue Growth %: +1.5%
Financial Fact:
Total operating expenses: 169.6M
Today's EPS Names:
CRMT, PKE, HELE, More
Revenue Growth %: +1.5%
Financial Fact:
Total operating expenses: 169.6M
Today's EPS Names:
CRMT, PKE, HELE, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q3 EPS of $7.16, $0.16 worse than the analyst estimate of $7.32. Revenue for the quarter came in at $799.5 million versus the consensus estimate of $812.87 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Eli Lilly: Q2 2026 IPR&D charge estimated at $3.02 per share on GAAP and non-GAAP basis
- Dollar Tree upgraded on earnings upside potential despite ongoing traffic woes
- Bain Capital Exited Flash Memory Maker Kioxia, Executive Says - Bloomberg
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
